These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 12591742

  • 1. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
    Iuliano R, Trapasso F, Le Pera I, Schepis F, Samà I, Clodomiro A, Dumon KR, Santoro M, Chiariotti L, Viglietto G, Fusco A.
    Cancer Res; 2003 Feb 15; 63(4):882-6. PubMed ID: 12591742
    [Abstract] [Full Text] [Related]

  • 2. Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo.
    Trapasso F, Yendamuri S, Dumon KR, Iuliano R, Cesari R, Feig B, Seto R, Infante L, Ishii H, Vecchione A, During MJ, Croce CM, Fusco A.
    Carcinogenesis; 2004 Nov 15; 25(11):2107-14. PubMed ID: 15231692
    [Abstract] [Full Text] [Related]

  • 3. Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).
    Trapasso F, Iuliano R, Boccia A, Stella A, Visconti R, Bruni P, Baldassarre G, Santoro M, Viglietto G, Fusco A.
    Mol Cell Biol; 2000 Dec 15; 20(24):9236-46. PubMed ID: 11094075
    [Abstract] [Full Text] [Related]

  • 4. Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.
    Martelli ML, Trapasso F, Bruni P, Berlingieri MT, Battaglia C, Vento MT, Belletti B, Iuliano R, Santoro M, Viglietto G, Fusco A.
    Exp Cell Res; 1998 Nov 25; 245(1):195-202. PubMed ID: 9828116
    [Abstract] [Full Text] [Related]

  • 5. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G.
    Carcinogenesis; 2005 Jun 25; 26(6):1021-34. PubMed ID: 15718252
    [Abstract] [Full Text] [Related]

  • 6. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T, Lin FF, Rao P, Lin MF.
    Prostate; 2003 Jun 01; 55(4):247-58. PubMed ID: 12712404
    [Abstract] [Full Text] [Related]

  • 7. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
    Massa A, Barbieri F, Aiello C, Iuliano R, Arena S, Pattarozzi A, Corsaro A, Villa V, Fusco A, Zona G, Spaziante R, Schettini G, Florio T.
    Ann N Y Acad Sci; 2004 Dec 01; 1030():264-74. PubMed ID: 15659806
    [Abstract] [Full Text] [Related]

  • 8. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.
    Scala S, Portella G, Fedele M, Chiappetta G, Fusco A.
    Proc Natl Acad Sci U S A; 2000 Apr 11; 97(8):4256-61. PubMed ID: 10759549
    [Abstract] [Full Text] [Related]

  • 9. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T, Yamazaki M, Minemura K, Imai Y, Inaba H, Suzuki S, Miyamoto T, Ichikawa K, Kakizawa T, Mori J, DeGroot LJ, Hashizume K.
    Cancer Gene Ther; 2002 Oct 11; 9(10):864-74. PubMed ID: 12224028
    [Abstract] [Full Text] [Related]

  • 10. The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue.
    Pera IL, Iuliano R, Florio T, Susini C, Trapasso F, Santoro M, Chiariotti L, Schettini G, Viglietto G, Fusco A.
    Oncogene; 2005 Apr 28; 24(19):3187-95. PubMed ID: 15735685
    [Abstract] [Full Text] [Related]

  • 11. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation.
    Florio T, Arena S, Thellung S, Iuliano R, Corsaro A, Massa A, Pattarozzi A, Bajetto A, Trapasso F, Fusco A, Schettini G.
    Mol Endocrinol; 2001 Oct 28; 15(10):1838-52. PubMed ID: 11579215
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T, Yamochi T, Ohnuma K, Iwata S, Kina S, Inamoto S, Tachibana M, Katsuoka Y, Dang NH, Morimoto C.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [Abstract] [Full Text] [Related]

  • 13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 01; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

  • 14. The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.
    Jandt E, Denner K, Kovalenko M, Ostman A, Böhmer FD.
    Oncogene; 2003 Jul 03; 22(27):4175-85. PubMed ID: 12833140
    [Abstract] [Full Text] [Related]

  • 15. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo.
    Li B, Liu X, Fan J, Qi R, Bo L, Gu J, Qian Q, Qian C, Liu X.
    J Gene Med; 2006 Oct 03; 8(10):1232-42. PubMed ID: 16900558
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM, Yao G.
    J Cell Physiol; 2003 Dec 03; 197(3):326-35. PubMed ID: 14566962
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines.
    Koh TY, Park SW, Park KH, Lee SG, Seol JG, Lee DW, Lee CT, Heo DS, Kim KH, Sung MW.
    Head Neck; 2003 Jan 03; 25(1):44-9. PubMed ID: 12478543
    [Abstract] [Full Text] [Related]

  • 19. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura T, Toguchida J.
    Clin Cancer Res; 2005 Apr 01; 11(7):2702-12. PubMed ID: 15814652
    [Abstract] [Full Text] [Related]

  • 20. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis.
    Iuliano R, Le Pera I, Cristofaro C, Baudi F, Arturi F, Pallante P, Martelli ML, Trapasso F, Chiariotti L, Fusco A.
    Oncogene; 2004 Nov 04; 23(52):8432-8. PubMed ID: 15378013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.